New MRI fingerprinting could sharpen brain tumor diagnosis
NCT ID NCT02956291
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new MRI technique called magnetic resonance fingerprinting (MRF) to see if it can improve how doctors diagnose and assess brain tumors. Researchers will compare MRF scans with standard tests, clinical details, and biopsy results in 172 people with brain tumors. The goal is to see if MRF provides more accurate information about tumor tissue, potentially reducing the need for contrast dye.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magnetic Resonance Fingerprinting (MRF) - a new MRI scanning technique
What this could lead to
If successful, this could lead to more accurate and faster diagnosis of brain tumors without needing contrast dye.
What could go wrong
This is an early-stage imaging study, not a treatment trial. The new technique may not prove more accurate than standard MRI, and results may not change patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States